CALGARY- Calgary researchers are recruiting patients for a clinical trial, as they try to find a drug that can repair the damage caused by relapsing and remitting forms of multiple sclerosis.
The trial will test two drugs currently approved for use to treat other conditions.
“One of them is called domperidone,” explains Dr. V Wee Yong, a neuroscientist with the Hotchkiss Brain Institute. “It’s currently used in Parkinson’s disease, but some time ago we also discovered the hormone prolactin can elicit repair in models of MS and this drug raises prolactin levels as a side effect.”
A sedative is also being tested.
Researchers will be recruiting patients through Calgary’s MS Clinic.
Anyone interested in learning more about this research and other studies can do so at the MS Connections Conference, which is being held in Calgary on September 19th and 20th.
Comments